Citigroup’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-144,436
| Closed | -$2.12M | – | 6165 |
|
|
2025
Q3 | $2.12M | Sell |
144,436
-71,889
| -33% | -$733K | ﹤0.01% | 2624 |
|
|
2025
Q2 | $2.12M | Buy |
216,325
+9,195
| +4% | +$76.1K | ﹤0.01% | 2587 |
|
|
2025
Q1 | $1.51M | Buy |
207,130
+94,789
| +84% | +$829K | ﹤0.01% | 2961 |
|
|
2024
Q4 | $879K | Buy |
112,341
+47,314
| +73% | +$390K | ﹤0.01% | 3454 |
|
|
2024
Q3 | $481K | Buy |
65,027
+29,360
| +82% | +$247K | ﹤0.01% | 3753 |
|
|
2024
Q2 | $286K | Sell |
35,667
-382,592
| -91% | -$3.42M | ﹤0.01% | 3707 |
|
|
2024
Q1 | $4.87M | Buy |
418,259
+203,657
| +95% | +$2.25M | ﹤0.01% | 1724 |
|
|
2023
Q4 | $2.4M | Buy |
214,602
+52,746
| +33% | +$485K | ﹤0.01% | 2082 |
|
|
2023
Q3 | $2.5M | Buy |
161,856
+27,294
| +20% | +$458K | ﹤0.01% | 1842 |
|
|
2023
Q2 | $2.55M | Sell |
134,562
-249,026
| -65% | -$4.37M | ﹤0.01% | 1992 |
|
|
2023
Q1 | $5.84M | Sell |
383,588
-155,091
| -29% | -$2.02M | ﹤0.01% | 1422 |
|
|
2022
Q4 | $6.86M | Buy |
538,679
+128,032
| +31% | +$1.15M | 0.01% | 1319 |
|
|
2022
Q3 | $2.38M | Buy |
410,647
+186,020
| +83% | +$817K | ﹤0.01% | 2029 |
|
|
2022
Q2 | $723K | Buy |
224,627
+223,764
| +25,929% | +$676K | ﹤0.01% | 2940 |
|
|
2022
Q1 | $3K | Sell |
863
-2,283
| -73% | -$14.7K | ﹤0.01% | 5955 |
|
|
2021
Q4 | $41K | Buy |
3,146
+1,993
| +173% | +$31.5K | ﹤0.01% | 5157 |
|
|
2021
Q3 | $23K | Buy |
1,153
+689
| +148% | +$12.6K | ﹤0.01% | 5170 |
|
|
2021
Q2 | $9K | Sell |
464
-88
| -16% | -$1.96K | ﹤0.01% | 5692 |
|
|
2021
Q1 | $13K | Sell |
552
-1,019
| -65% | -$23.5K | ﹤0.01% | 5476 |
|
|
2020
Q4 | $38K | Buy |
1,571
+1,259
| +404% | +$32.2K | ﹤0.01% | 6225 |
|
|
2020
Q3 | $8K | Sell |
312
-103
| -25% | -$3.27K | ﹤0.01% | 6747 |
|
|
2020
Q2 | $8K | Sell |
415
-494
| -54% | -$12K | ﹤0.01% | 7130 |
|
|
2020
Q1 | $23K | Buy |
909
+319
| +54% | +$9.33K | ﹤0.01% | 6601 |
|
|
2019
Q4 | $15K | Buy |
+590
| New | +$16.4K | ﹤0.01% | 7052 |
|
Other funds holding ETNB
Citigroup's ETNB Position: Q4 2025 in Review
Citigroup sold out of 89bio (ETNB) in Q4 2025, closing a stake of 144,436 shares — an estimated $2.12M sold.
Citigroup first reported a position in ETNB in Q4 2019 and held it in 24 quarters. The position peaked at $6.86M in Q4 2022. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Citigroup reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Citigroup sold 144,436 89bio shares in Q4 2025, an estimated $2.12M.
- Citigroup first reported a position in 89bio in Q4 2019 and held it in 24 quarters.
- Citigroup's 89bio position peaked at $6.86M in Q4 2022.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.